Viatris (VTRS) Q1 Earnings and Revenues Miss Estimates [Yahoo! Finance]
Viatris Inc. (VTRS)
Company Research
Source: Yahoo! Finance
This compares to earnings of $0.78 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -1.47%. A quarter ago, it was expected that this generic drugmaker would post earnings of $0.67 per share when it actually produced earnings of $0.61, delivering a surprise of -8.96%. Over the last four quarters, the company has surpassed consensus EPS estimates two times. Viatris , which belongs to the Zacks Medical Services industry, posted revenues of $3.66 billion for the quarter ended March 2024, missing the Zacks Consensus Estimate by 2.12%. This compares to year-ago revenues of $3.73 billion. The company has topped consensus revenue estimates just once over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Viatris shares have added abo
Show less
Read more
Impact Snapshot
Event Time:
VTRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTRS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTRS alerts
High impacting Viatris Inc. news events
Weekly update
A roundup of the hottest topics
VTRS
News
- Prevent Blindness Launches "It Started With an Eye Exam" Campaign to Encourage, Educate and Empower the Public to Make Vision and Eye Health a Part of Overall Health Care [Yahoo! Finance]Yahoo! Finance
- Viatris Inc. (NASDAQ:VTRS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
- Weak Sales From Lipitor, Norvasc Hurt Viatris' Q1 Earnings, Lowers Annual Forecast [Yahoo! Finance]Yahoo! Finance
- Viatris' (VTRS) Q1 Earnings & Sales Lag Estimates, Stock Down [Yahoo! Finance]Yahoo! Finance
VTRS
Earnings
- 5/9/24 - Miss
VTRS
Sec Filings
- 5/9/24 - Form 10-Q
- 5/9/24 - Form 8-K
- 4/26/24 - Form 10-K/A
- VTRS's page on the SEC website